Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rokland
Limerick, Pennsylvania, USArockland.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Rockland Immunochemicals is a leading global manufacturer of antibodies and reagents for life science research, diagnostics, and drug discovery. Founded in 1962, the company provides a comprehensive portfolio of primary and secondary antibodies, proteins, peptides, and assay kits, with a focus on high-quality manufacturing and rigorous validation. Rockland also offers specialized custom services, including antibody development, assay optimization, and large-scale manufacturing under GMP-like conditions. Their products support research across various therapeutic areas, including oncology, immunology, and infectious diseases, serving academic, clinical, and industrial laboratories worldwide.
- Modalities
- AntibodyProteinPeptidesRecombinant protein
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Rokland.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rokland.